| Dr Chantelle Dufresne, DO | |
|
1800 Se Tiffany Ave, Port St Lucie, FL 34952-7521 | |
| (772) 335-4000 | |
| Not Available |
| Full Name | Dr Chantelle Dufresne |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 12 Years |
| Location | 1800 Se Tiffany Ave, Port St Lucie, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083966808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | UO 2986 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic Martin North Hospital | Stuart, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paragon Contracting Services Llc | 3971417825 | 264 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.
SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce retained foreign objects will be presented and discussed at two upcoming conferences.
Presently keratoconus is treated through eyeglasses, hard contact lenses, and a newer treatment, INTACS plastic rings inserted into the mid layer of the cornea to flatten it, changing the shape and location of the cone.
Just over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder, a study of more than 13,000 overdose deaths has found.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that data from a phase I single-agent clinical trial of brentuximab vedotin (SGN-35) will be published in the November 4, 2010 issue of the New England Journal of Medicine.
› Verified 2 days ago
| Entity Name | Inphynet Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073556767 PECOS PAC ID: 7416865811 Enrollment ID: O20031105000125 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.
SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce retained foreign objects will be presented and discussed at two upcoming conferences.
Presently keratoconus is treated through eyeglasses, hard contact lenses, and a newer treatment, INTACS plastic rings inserted into the mid layer of the cornea to flatten it, changing the shape and location of the cone.
Just over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder, a study of more than 13,000 overdose deaths has found.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that data from a phase I single-agent clinical trial of brentuximab vedotin (SGN-35) will be published in the November 4, 2010 issue of the New England Journal of Medicine.
› Verified 2 days ago
| Entity Name | Paragon Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20041207001148 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.
SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce retained foreign objects will be presented and discussed at two upcoming conferences.
Presently keratoconus is treated through eyeglasses, hard contact lenses, and a newer treatment, INTACS plastic rings inserted into the mid layer of the cornea to flatten it, changing the shape and location of the cone.
Just over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder, a study of more than 13,000 overdose deaths has found.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that data from a phase I single-agent clinical trial of brentuximab vedotin (SGN-35) will be published in the November 4, 2010 issue of the New England Journal of Medicine.
› Verified 2 days ago
| Entity Name | Emergency Medicine Services Of Fl Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043917180 PECOS PAC ID: 8426413931 Enrollment ID: O20230504001881 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.
SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce retained foreign objects will be presented and discussed at two upcoming conferences.
Presently keratoconus is treated through eyeglasses, hard contact lenses, and a newer treatment, INTACS plastic rings inserted into the mid layer of the cornea to flatten it, changing the shape and location of the cone.
Just over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder, a study of more than 13,000 overdose deaths has found.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that data from a phase I single-agent clinical trial of brentuximab vedotin (SGN-35) will be published in the November 4, 2010 issue of the New England Journal of Medicine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chantelle Dufresne, DO 300 Via Royale, Apt 309, Jupiter, FL 33458-6971 Ph: () - | Dr Chantelle Dufresne, DO 1800 Se Tiffany Ave, Port St Lucie, FL 34952-7521 Ph: (772) 335-4000 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.
SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce retained foreign objects will be presented and discussed at two upcoming conferences.
Presently keratoconus is treated through eyeglasses, hard contact lenses, and a newer treatment, INTACS plastic rings inserted into the mid layer of the cornea to flatten it, changing the shape and location of the cone.
Just over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder, a study of more than 13,000 overdose deaths has found.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that data from a phase I single-agent clinical trial of brentuximab vedotin (SGN-35) will be published in the November 4, 2010 issue of the New England Journal of Medicine.
› Verified 2 days ago
Nagy Saber Farag, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7043 Us Highway 1, Port St Lucie, FL 34952 Phone: 727-309-1412 Fax: 352-564-4222 | |
Dr. Austin Hudson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-335-4000 | |
Ilka N. Langston Mckinney, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1800 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-398-3800 | |
Joseph Richard Cariello, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1800 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-398-3800 | |
Hicham El Alami, D.O Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-335-4000 | |
Dr. Seth Alexander Martin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12348 Sw Keating Dr, Port St Lucie, FL 34987 Phone: 713-444-9010 |